나머지 환자들은 수행능력과 종양의 특성에 따라 세분화시켜야 하며 새로운 환자 맞춤형 치료지침이 필요하다고 결론지었다.
It was concluded that the remaining patients should be subdivided according to performance and tumor characteristics and that new patient-specific treatment guidelines are needed.